Novaplex™ Entero-DR
Targets
- Carbapenemase genes (NDM)
- Carbapenemase genes (KPC)
- Carbapenemase genes (OXA48)
- Carbapenemase genes (VIM)
- Extended Spectrum Beta Lactamase gene (ESBL)
- Carbapenemase genes (IMP)
- CTX-M genes
- Vancomycin resistance genes (VanA, VanB) genes
Description
Targets 8
Sample Types
- Rectal swab
- Bacterial colonies
Key Features
- Detection of 8 different resistance genes in a single reaction
- Provides whole process control
- Reporting of individual Ct values Multiplex assay provides 768 data points for 96 samples
Compatible instrumentation
Automated Extraction & PCR Setup
- Seegene NIMBUS
- Seegene STARlet
Real-time PCR
- CFX96 Real time PCR Detection System (Bio Rad)
- CFX96 Opus (Bio-Rad)
- CFX96 Touch Real Time PCR Detection System (Bio Rad)
Seegene Viewer Software
- Quick and easy data analysis and interpretation
- Interface specialized for multiplex testing
• Novaplex™ Assays are for Research Use Only. Not for use in diagnostic procedures. • Seegene NIMBUS, Seegene STARlet, Seegene Launcher and Viewer software are For Research Use Only. Not for Use in Diagnostic Procedures.
Additional information
| Volume | 124 rxns |
|---|
Related products
-
Targets
- Mycobacterium tuberculosis (MTB)
- RIF-R (18 mutations in rpoB)
- INH-R (4 mutations in katG)
- INH-R (3 mutations in inhA promoter)
-
Targets
- Mycoplasma genitalium (MG)
- A2058C (mutation of 23S rRNA)
- A2058G (mutation of 23S rRNA)
- A2058T (mutation of 23S rRNA)
- A2059C (mutation of 23S rRNA)
- A2059G (mutation of 23S rRNA)
- A2059T (mutation of 23S rRNA)
-
Targets
- Mycobacterium tuberculosis (MTB)
- Extensive drug resistance (13 mutations)
- Injectable drug-resistance (6 mutations)
- Fluoroquinolone-resistance (7 mutations)
-
Targets
- A2059G (mutation of 23S rRNA)
- C2611T (mutation of 23S rRNA)
- S91F (mutation of gyrase A)
- Neisseria gonorrhoeae (NG1)
- Neisseria gonorrhoeae (NG2)